Tim Boyle Abbott (NYSE:ABT) has launched a new nutritional product brand called Protality aimed at helping preserve muscle mass in people pursuing weight loss through GLP-1 drugs, surgery or calorie-restricted diets. The high protein shakes are designed to nourish muscles for up to seven hours after consumption.

蒂姆·博伊尔·雅培（纽约证券交易所代码：ABT）推出了一个新的营养产品品牌，名为Protility，旨在帮助通过GLP-1药物、手术或限制热量饮食减肥的人保持肌肉质量。这种高蛋白奶昔被设计用来在食用后7小时内滋养肌肉。

The product’s formulation is equivalent in nutrition to Abbott’s Ensure Max Protein drink, according to a company statement. Abbott said the brand is aimed particularly at overweight or obese people taking weight-loss drugs. During the company’s Q3 earnings call, Abbott management said it saw GLP-1 drugs creating an opportunity for its nutritional products.

根据公司声明，该产品的配方在营养方面与雅培的Ensure Max蛋白饮料相当。雅培表示，该品牌特别针对服用减肥药的超重或肥胖人群。在公司第三季度财报电话会议上，雅培管理层表示，它看到GLP-1药物为其营养产品创造了机会。

More on Abbott Laboratories The King Is Back: Abbott Laboratories' Path To >11% Annual Returns Abbott: Strong R&D Pipeline Continues To Drive Growth; Reiterate 'Strong Buy' Abbott Laboratories (ABT) Q4 2023 Earnings Call Transcript Abbott Q4 beat driven by MedTech Abbott Laboratories Non-GAAP EPS of $1.19 in-line, revenue of $10.24B beats by $50M .

更多关于雅培实验室的信息国王回来了：雅培实验室的年回报率达到11%以上雅培：强大的研发渠道继续推动增长；重申“强势买入”雅培实验室（Abbott Laboratories）2023年第四季度盈利通话记录，受MedTech Abbott Laboratories非公认会计准则每股收益1.19美元的推动，雅培第四季度盈利超过1000万美元。